{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:11:07Z","timestamp":1786997467540,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009664","name":"Sociedad Espa\u00f1ola de Cardiolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.thromres.2020.08.041","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T04:48:03Z","timestamp":1598590083000},"page":"215-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Association of fractalkine with functional severity of heart failure and impact on clopidogrel efficacy in patients with ischemic heart disease"],"prefix":"10.1016","volume":"196","author":[{"given":"Ana Lucrecia","family":"Marcano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie Marisol","family":"Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Besteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Gomez-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Roura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Gracida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Teruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Romaguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Gabriela","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Cequier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan A.","family":"G\u00f3mez-Hospital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Comin-Colet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-9575","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.08.041_bb0005","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2020.08.041_bb0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1538-7836.2007.02288.x","article-title":"Antithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implications","volume":"5","author":"Dotsenko","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.041_bb0015","first-page":"CD003333","article-title":"Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm","volume":"9","author":"Shantsila","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.thromres.2020.08.041_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2013.07.007","article-title":"Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives","volume":"2","author":"Gurbel","year":"2014","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.thromres.2020.08.041_bb0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2020.08.041_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jjcc.2018.03.001","article-title":"Dual antiplatelet therapy after coronary stent implantation: individualizing the optimal duration","volume":"72","author":"Lugo","year":"2018","journal-title":"J. Cardiol."},{"key":"10.1016\/j.thromres.2020.08.041_bb0035","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1160\/TH12-03-0195","article-title":"Fractalkine is an independent predictor of mortality in patients with advanced heart failure","volume":"108","author":"Richter","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.041_bb0040","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/ATVBAHA.112.250720","article-title":"Fractalkine activates a signal transduction pathway similar to P2Y12 and is associated with impaired clopidogrel responsiveness","volume":"32","author":"Flierl","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.08.041_bb0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1160\/TH13-08-0640","article-title":"Fractalkine promotes platelet activation and vascular dysfunction in congestive heart failure","volume":"111","author":"Hildemann","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.041_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11239-012-0846-z","article-title":"Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation","volume":"35","author":"Ferreiro","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2020.08.041_bb0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1538-7836.2009.03709.x","article-title":"Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement","volume":"8","author":"Sibbing","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.041_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1160\/TH13-01-0057","article-title":"Clopidogrel pretreatment in primary percutaneous coronary intervention: prevalence of high on-treatment platelet reactivity and impact on preprocedural patency of the infarct-related artery","volume":"110","author":"Ferreiro","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.041_bb0065","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/CIRCHEARTFAILURE.112.000381","article-title":"Is there a rationale for antiplatelet therapy in acute heart failure?","volume":"6","author":"Mentz","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.thromres.2020.08.041_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-5273(00)00300-4","article-title":"Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge","volume":"75","author":"Davis","year":"2000","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2020.08.041_bb0075","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1536\/ihj.18-422","article-title":"Increased plasma soluble fractalkine in patients with chronic heart failure and its clinical significance","volume":"60","author":"Ji","year":"2019","journal-title":"Int. Heart J."},{"key":"10.1016\/j.thromres.2020.08.041_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1388-9842(99)00029-X","article-title":"Increased soluble platelet\/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy","volume":"1","author":"Serebruany","year":"1999","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.thromres.2020.08.041_bb0085","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0002-9149(99)00098-3","article-title":"Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure","volume":"83","author":"O\u2019Connor","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2020.08.041_bb0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/07853890802227089","article-title":"Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure","volume":"41","author":"Chung","year":"2009","journal-title":"Ann. Med."},{"key":"10.1016\/j.thromres.2020.08.041_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000057283","volume":"32","author":"Serebruany","year":"2002","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.thromres.2020.08.041_bb0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1160\/TH12-04-0271","article-title":"Fractalkine\u2014a local inflammatory marker aggravating platelet activation at the vulnerable plaque","volume":"108","author":"Flierl","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.08.041_bb0105","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.21.6.923","article-title":"Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions","volume":"21","author":"Greaves","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.08.041_bb0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1253\/circj.CJ-09-0484","article-title":"Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris","volume":"74","author":"Ikejima","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.thromres.2020.08.041_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.yjmcc.2008.05.009","article-title":"Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure","volume":"45","author":"Husberg","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.thromres.2020.08.041_bb0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2840-10-50","article-title":"Changes of dendritic cells and fractalkine in type 2 diabetic patients with unstable angina pectoris: a preliminary report","volume":"10","author":"Yao","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.thromres.2020.08.041_bb0125","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2174\/138955709789055252","article-title":"The CX(3)C-chemokine fractalkine in kidney diseases","volume":"9","author":"Koziolek","year":"2009","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.thromres.2020.08.041_bb0130","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.ATV.0000190672.36490.7b","article-title":"Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy","volume":"25","author":"Dam\u00e5s","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2020.08.041_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvr221","article-title":"Detrimental effect of fractalkine on myocardial ischaemia and heart failure","volume":"92","author":"Xuan","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2020.08.041_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.thromres.2019.01.021","article-title":"High and low on-treatment platelet reactivity to P2Y12 inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention","volume":"175","author":"Ferreiro","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2020.08.041_bb0145","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.08.041_bb0150","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.08.041_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40256-013-0022-7","article-title":"Antiplatelet and anticoagulant therapy for atherothrombotic disease: the role of current and emerging agents","volume":"13","author":"Angiolillo","year":"2013","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.thromres.2020.08.041_bb0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1538-7836.2007.02812.x","article-title":"The residual platelet aggregation after deployment of intracoronary stent (PREDICT) score","volume":"6","author":"Geisler","year":"2008","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820304898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820304898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:44:30Z","timestamp":1758735870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820304898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"alternative-id":["S0049384820304898"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.08.041","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of fractalkine with functional severity of heart failure and impact on clopidogrel efficacy in patients with ischemic heart disease","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}